Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3019% below fair value

$0.63−0.05 (-7.36%)

Close on Nov 13, 2026Market cap $66.74MP/E –Yield –

Hyperfine EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Hyperfine's EPS for the twelve months ending Sep 30, 2026 was -$0.30. For fiscal 2025 it was -$0.43. The highest annual figure on record is -$0.43 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$0.43	–
FY2024	Dec 31, 2024	-$0.56	–
FY2023	Dec 31, 2023	-$0.62	–
FY2022	Dec 31, 2022	-$1.04	–
FY2021	Dec 31, 2021	-$17.57	–
FY2020	Dec 31, 2020	-$15.38	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.06	–
Q2 FY2026	Jun 30, 2026	-$0.09	–
Q1 FY2026	Mar 31, 2026	-$0.09	–
Q4 FY2025	Dec 31, 2025	-$0.06	–
Q3 FY2025	Sep 30, 2025	-$0.14	–
Q2 FY2025	Jun 30, 2025	-$0.12	–
Q1 FY2025	Mar 31, 2025	-$0.12	–
Q4 FY2024	Dec 31, 2024	-$0.14	–
Q3 FY2024	Sep 30, 2024	-$0.14	–
Q2 FY2024	Jun 30, 2024	-$0.14	–
Q1 FY2024	Mar 31, 2024	-$0.14	–
Q4 FY2023	Dec 31, 2023	-$0.15	–
Q3 FY2023	Sep 30, 2023	-$0.15	–
Q2 FY2023	Jun 30, 2023	-$0.15	–
Q1 FY2023	Mar 31, 2023	-$0.17	–
Q4 FY2022	Dec 31, 2022	-$0.18	–
Q3 FY2022	Sep 30, 2022	-$0.19	–
Q2 FY2022	Jun 30, 2022	-$0.33	–
Q1 FY2022	Mar 31, 2022	-$0.34	–
Q3 FY2021	Sep 30, 2021	-$8.66	–
Q2 FY2021	Jun 30, 2021	-$8.80	–
Q1 FY2021	Mar 31, 2021	-$4.86	–